Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 20,000 shares at $5.10 ($102K) on 2019-12-16, disclosed to the SEC on 2019-12-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |
| ALDX | BUY | 2019-09-25 | $101K | — | Filing → |